Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04045795
Title Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL | AUS

Facility Status City State Zip Country Details
~Banner MD Anderson Cancer Center Site Number : 8400005 Gilbert Arizona 85234 United States Details
City of Hope Site Number : 8400002 Duarte California 91010 United States Details
Gabrail Cancer Center Site Number : 8400001 Canton Ohio 44718 United States Details
Investigational Site Number : 0360002 Blacktown New South Wales 2148 Australia Details
Investigational Site Number : 0360001 Wollongong New South Wales 2500 Australia Details
Investigational Site Number : 0360004 Fitzroy Victoria 3065 Australia Details
Investigational Site Number : 0360003 Richmond Victoria 3121 Australia Details
Investigational Site Number : 0560001 Leuven 3000 Belgium Details
Investigational Site Number : 2500001 Nantes 44093 France Details
Investigational Site Number : 2500002 TOULOUSE Cedex 9 31059 France Details
Investigational Site Number : 3920002 Okayama-shi Okayama 701-1192 Japan Details
Investigational Site Number : 3920001 Shibuya-ku Tokyo 150-8935 Japan Details
Investigational Site Number : 7240002 Santander Cantabria 39008 Spain Details
Investigational Site Number : 7240001 Badalona Catalunya [Cataluña] 08916 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field